Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY: IQV )

185.19 +3.76 (+2.07%)
Official Closing Price Updated: 7:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,100,340
Open 183.12
Bid (Size) 178.55 (1)
Ask (Size) 207.45 (1)
Prev. Close 181.43
Today's Range 182.03 - 185.53
52wk Range 179.28 - 256.34
Shares Outstanding 176,100,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and... 
Via StockStory

Performance

YTD
-5.09%
-5.09%
1 Month
-5.54%
-5.54%
3 Month
-6.04%
-6.04%
6 Month
-22.64%
-22.64%
1 Year
-26.72%
-26.72%

More News

Read More
IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services
From IQVIA
Via Business Wire
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
Via StockStory
Earnings Scheduled For February 6, 2025
Via Benzinga
Analyst Expectations For IQVIA Hldgs's Future
Via Benzinga
IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials
From IQVIA
Via Business Wire
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor
Via Benzinga
IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025
From IQVIA
Via Business Wire
IQVIA Releases 2024 Sustainability Report
From IQVIA
Via Business Wire
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
Via StockStory
West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For
Via StockStory
Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
Via Benzinga
Topics Stocks
Exposures US Equities
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
Via Benzinga
Gapping S&P500 stocks in Thursday's session
Via Chartmill
Wondering what's happening in today's S&P500 pre-market session?
Via Chartmill
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars
Via StockStory
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For
Via StockStory
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
From IQVIA
Via Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
From IQVIA
Via Business Wire
Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
From IQVIA
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.